Clostridium Difficile Diagnostics Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-03-27　·　153 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1,118.8 Mn
2033 年預估規模: USD 1,852.1 Mn
年複合成長率 CAGR: 7.5%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-03-27頁數 153報告編號 CMI5315

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Clostridium Difficile Diagnostics Market, By Diagnostic Test (Enzyme Immunoassays, Real-Time Polymerase Chain Reaction (RT-PCR), Nucleic Amplification Tests (NAAT), Stool Test (GDH Antigen Test Toxin A and B Test), Blood Test, Colonoscopy or Sigmoidoscopy, Others), By End User (Hospitals, Diagnostic Centers, Specialty Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Clostridium difficile is a disease caused by bacteria. The illness manifests as a variety of symptoms, such as diarrhea, nausea, and colon inflammation. Furthermore, since antibiotics kill healthy bacteria in the body and promote the growth of C. difficile bacteria, they are also responsible for clostridium difficile infection when taken frequently. Watery diarrhoea, dehydration, fever, nausea, loss of appetite, and weight loss are typical signs of clostridium difficile infection. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection. Market Dynamics Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its “Making a Difference” award to CutisPharma, Inc.—a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options. Key features of the study • This report provides an in-depth analysis of the global clostridium difficile diagnostics market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global clostridium difficile diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Inc., Abbott Laboratories, Trinity Biotech Plc., Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global Clostridium Difficile Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1 • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Clostridium Difficile Diagnostics market Clostridium Difficile Diagnostics Market Segmentation • By Diagnostic Test (Revenue, USD Mn, 2020 - 2033) o Enzyme Immunoassays o Real-Time Polymerase Chain Reaction (RT-PCR) o Nucleic Amplification Tests (NAAT) o Stool Test  GDH Antigen Test  Toxin A and B Test o Blood Test o Colonoscopy or Sigmoidoscopy o Others • By End User Insights (Revenue, USD Mn, 2020 - 2033) o Hospitals o Diagnostic Centers o Specialty Clinics o Others • By Region Insights (Revenue, USD Mn, 2020 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Key Players o Hoffmann-La Roche Ltd, o Thermo Fisher Scientific o Merck & Co., Inc. o Pfizer, Inc. o Actelion Pharmaceuticals, Inc. o Abbott Laboratories o Trinity Biotech Plc. o Summit Therapeutics o Sanofi S.A. o Novartis AG o AstraZeneca Plc

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Diagnostic Test  Market Snapshot, By End User  Market Snapshot, By Region  Market Opportunity Map 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Key Highlights o Recent Product Approvals/Launch o Epidemiology o Market Trends o Porter’s Analysis o PEST Analysis o Technology Advancement o Regulatory Scenario 4. Global Clostridium Difficile Diagnostics Market, By Diagnostic Test, 2020–2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2020-2033  Segment Trends o Enzyme Immunoassays  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Real-Time Polymerase Chain Reaction (RT-PCR)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Nucleic Amplification Tests (NAAT)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Stool Test  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o GDH Antigen Test o Toxin A and B Test o Blood Test  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Colonoscopy or Sigmoidoscopy  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) 5. Global Clostridium Difficile Diagnostics Market, By End User, 2020–2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2020–2033  Segment Trends o Hospitals  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Diagnostic Centers  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Specialty Clinics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn) 6. Global Clostridium Difficile Diagnostics Market, By Region, 2020–2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2017–2030  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn) o UK o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2020–2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020–2033, (USD Mn) o North Africa o Central Africa o South Africa 7. Competitive Landscape o F. Hoffmann-La Roche Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Thermo Fisher Scientific  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Merck & Co., Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Pfizer, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Actelion Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Trinity Biotech Plc  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Summit Therapeutics  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sanofi S.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AstraZeneca Plc  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 8. Section o Research Methodology o About Us *Browse 25 market data tables and 29 figures on “Global Clostridium Difficile Diagnostics Market” - forecast to 2033

提及公司

Hoffmann-La Roche Ltd,Thermo Fisher ScientificMerck & Co., Inc.Pfizer, Inc.Actelion Pharmaceuticals, Inc.Abbott LaboratoriesTrinity Biotech Plc.Summit TherapeuticsSanofi S.A.Novartis AGAstraZeneca Plc

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們